REGN Regeneron Pharmaceuticals Inc

USD 743.35 -1.25 ( -0.17)%
Icon

Regeneron Pharmaceuticals Inc (REGN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 743.35

-1.25 (-0.17)%

USD 92.70B

0.65M

N/A

USD 755.40 (+1.62%)

Icon

REGN

Regeneron Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 743.35
-1.25 ( -0.17)%

Regeneron Pharmaceuticals Inc (REGN) Stock Forecast

Show ratings and price targets of :
USD 1,185.06
(+59.42%)

Based on the Regeneron Pharmaceuticals Inc stock forecast from 18 analysts, the average analyst target price for Regeneron Pharmaceuticals Inc is USD 1,185.06 over the next 12 months. Regeneron Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Regeneron Pharmaceuticals Inc is Bullish , which is based on 10 positive signals and 4 negative signals. At the last closing, Regeneron Pharmaceuticals Inc’s stock price was USD 743.35. Regeneron Pharmaceuticals Inc’s stock price has changed by -7.58% over the past week, -24.97% over the past month and -7.27% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...